Why Is JBT MAREL CORP (JBTM) Stock Down Today?

JBT Marel Corp (JBTM) fell 6.88% to $132.47 in Monday trading, marking a sharp decline driven by the company's downward revision of its full-year 2026 earnings guidance. The stock opened at $131.99 and traded flat throughout the session with no intraday movement. The move follows the release of the company’s Q2 2026 earnings call and presentation, which highlighted a $1.95 adjusted earnings per share result that missed estimates and a lowered outlook for the year.

What Happened

The company announced a reduction in its FY2026 GAAP EPS guidance from $4.70 to $5.15 to $4.20 to $4.70, below the current estimate of $4.88. Similarly, adjusted EPS guidance was cut from $8.00 to $8.50 to $7.85 to $8.35, below the $8.28 estimate. These revisions came alongside a Q2 sales result of $981 million that also fell short of the $988.467 million estimate. The earnings call highlighted challenges in the Prepared Food segment and outlined a path to achieving a 20% adjusted EBITDA margin by 2028, supported by expected annual savings of $25 million to $30 million. Despite these longer-term goals, the near-term outlook and execution issues weighed on sentiment.

What The Data Shows

JBTM has a market cap of $7.4 billion and a P/E ratio of 41.1, reflecting a high valuation relative to earnings. The stock is currently trading within its 52-week range of $113.67 to $170.19. Recent volume has been minimal, with no shares traded so far in the session, and no unusual options activity reported. Retail traders have not shown significant movement in social platforms, and no major insider transactions have occurred in the past 90 days. However, former President Donald J. Trump has made several small trades in the stock over the past five months, including a recent purchase of $50,001 to $100,000 on March 30.

What To Watch

The stock has no upcoming earnings date but will require continued monitoring for coverage breadth and potential follow-up from analysts. Oppenheimer recently initiated coverage with an Outperform rating and a $175 price target, which may influence future positioning.